Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
Authors
Keywords
Blood plasma, Uric acid, Chronic kidney disease, Renal system, Ejection fraction, Body mass index, Cardiac hypertrophy, HbA1c
Journal
PLoS One
Volume 12, Issue 8, Pages e0182699
Publisher
Public Library of Science (PLoS)
Online
2017-08-11
DOI
10.1371/journal.pone.0182699
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
- (2017) Yoichiro Otaki et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hyperuricemia as an independent risk factor for major cardiovascular events
- (2017) Vincenzo Capuano et al. Journal of Cardiovascular Medicine
- Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study
- (2016) Johannes Nossent et al. BMC Cardiovascular Disorders
- A Body Shape Index and Body Roundness Index: Two new body indices for detecting association between obesity and hyperuricemia in rural area of China
- (2016) Naijin Zhang et al. European Journal of Internal Medicine
- Effects of topiroxostat and febuxostat on urinary albumin excretion and plasma xanthine oxidoreductase activity in db/db mice
- (2016) Takashi Nakamura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS
- (2016) Takayo Murase et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- A highly sensitive assay for xanthine oxidoreductase activity using a combination of [13C2,15N2]xanthine and liquid chromatography/triple quadrupole mass spectrometry
- (2016) Takayo Murase et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study
- (2016) Tanya Keenan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Weight Loss, Xanthine Oxidase, and Serum Urate Levels: A Prospective Longitudinal Study of Obese Patients
- (2016) Pascal Richette et al. ARTHRITIS CARE & RESEARCH
- Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy
- (2016) Dijana J. Miric et al. Journal of Diabetes Research
- Weight Loss Mediated Reduction in Xanthine Oxidase Activity and Uric Acid Clearance in Adolescents with Severe Obesity
- (2016) Harrison K. Tam et al. Childhood Obesity
- Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis
- (2016) Jon White et al. Lancet Diabetes & Endocrinology
- Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages
- (2016) Suguru Tanaka et al. PLoS One
- Xanthine Oxidase and Cardiovascular Risk in Obese Children
- (2016) Harrison K. Tam et al. Childhood Obesity
- Uric Acid and Cardiovascular Events: A Mendelian Randomization Study
- (2015) M. E. Kleber et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Liver Inflammation and Metabolic Signaling in ApcMin/+ Mice: The Role of Cachexia Progression
- (2015) Aditi A. Narsale et al. PLoS One
- Hyperuricemia, Gout, and Cardiovascular Disease: An Update
- (2015) Aryeh M. Abeles Current Rheumatology Reports
- Xanthine oxidoreductase in cancer: more than a differentiation marker
- (2015) Maria Giulia Battelli et al. Cancer Medicine
- Heparin-induced thrombocytopenia due to heparin lock in a hemodialysis patient: A case report
- (2014) Koon Ming Chan et al. Hemodialysis International
- Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity
- (2014) Sho-ichi Yamagishi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies
- (2014) Ji Wang et al. PLoS One
- Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
- (2013) T. M. Palmer et al. BMJ-British Medical Journal
- Diuretic use in renal disease
- (2011) Domenic A. Sica Nature Reviews Nephrology
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
- (2010) Andrew S. Levey et al. KIDNEY INTERNATIONAL
- Revised Equations for Estimated GFR From Serum Creatinine in Japan
- (2009) Seiichi Matsuo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started